In Vivo bolsters editorial team by appointing William Looney

New York, Jan. 30, 2017 --

Informa’s Pharma Intelligence vertical is part of Informa’s Business Intelligence Division which provides specialist data, intelligence and insight to businesses, helping them make better decisions, gain competitive advantage and enhance return on investment.

In Vivo bolsters editorial team by appointing William Looney

Life sciences publication, In Vivo, part of the Pharma Intelligence vertical of Informa’s Business Intelligence Division, has appointed industry veteran William Looney as its new executive editor.

William joins from Pharmaceutical Executive Magazine where he was editor-in-chief. He started his career at the Economist Intelligence Unit becoming senior editor, and moved on to a number of public affairs and communications roles in the pharmaceutical industry – including ten years as senior director at Pfizer.

In his new role, based in the New York office, William will be responsible for developing and refining the publication’s content proposition to cater for the needs of its c-suite audience, with a focus on providing insight into the risks and opportunities the industry faces. In addition, he will be supporting the senior management team in achieving the organization’s overall commercial objectives.

In Vivo, which turns 35 this year, is the only strategically-focused business resource covering the global medical industry. Available in both online and print, its key areas of focus are pharma, medtech and diagnostics.

Commenting on his appointment, William said: “In Vivo is recognized as the gold standard in strategic insight for the life sciences industry. It is our job to keep senior executives informed and enable them to make profitable decisions. We deliver the insight they need to construct winning strategies, combat competitors’ plans, and anticipate future industry and market developments.”

“I’m looking forward to not only maintaining In Vivo’s reputation, but also enhancing the publication’s visibility in the market.”

Karen Coleman, Head of In Vivo, said: “William’s expertise stems from four decades in business intelligence and life sciences across a range of functions. This is a key appointment for us, and we are certain he will take In Vivo from strength to strength during a crucial period for the global life sciences industry.”

ENDS

For more information please contact:

Karen Coleman
[email protected]
+44 (0)20 755 19409

About Informa’s Pharma Intelligence vertical
Informa’s Pharma Intelligence vertical is part of Informa’s Business Intelligence Division which provides specialist data, intelligence and insight to businesses, helping them make better decisions, gain competitive advantage and enhance return on investment. It has a portfolio of more than 100 digital subscription products, providing critical intelligence to niche communities within five core industry verticals: Pharma & Healthcare, Finance, Maritime & Law, Technology, Media & Telecoms and Agriculture & Food. https://pharmaintelligence.informa.com

About Informa PLC
Informa operates at the heart of the Knowledge and Information Economy. It is one of the world’s leading business intelligence, academic publishing, knowledge and events businesses. With more than 6,500 employees globally, it has a presence in all major geographies, including North America, South America, Asia, Europe, the Middle East and Africa.

For more information please contact:

Karen Coleman
[email protected]
+44 (20) 755 19409